Amylyx Pharmaceuticals Inc (AMLX)

14.37 -2.31%

Amylyx Pharmaceuticals Inc (AMLX) is currently trading at $14.37. This represents a loss of 2.31% from the previous session. With a market capitalization of $1.58B, AMLX is a key component of the Health Care sector. Investors looking to trade AMLX should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade AMLX commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Amylyx Pharmaceuticals Inc (AMLX) shows a bearish trend. Analysts are watching the 14.99 level closely.

Fundamentals
Mkt Cap1.58B
P/E Ratio0.0000
Volume592,123
Others Watching (By Market Cap)
VKTX
Viking Therapeu $33.12
-1.87% ICUI
ICU Medical Inc $155.12
+1.74% CORT
Corcept Therape $36.22
-0.71% LGND
Ligand Pharmace $191.39
+1.26% ADMA
ADMA Biologics $15.68
+1.03%
60-Day Technical Chart
Advanced Charting

Need more indicators for AMLX? Use the world's #1 platform.

Open AMLX on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $14
Metric AMLX
-2.31% 		F
+1.62% 		AAL
+1.29% 		SMR
-1.86%
Price $14.37 $14.43 $13.32 $13.18
Mkt Cap $1.58B $57.57B $8.80B $3.99B
- View → View → View →
Latest Headlines
Amylyx schedules March 3 call on 2025 results and company updates Stock Titan • Feb 24, 2026 HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR Newswire • Jan 29, 2026 AMLX: B of A Securities Raises Target Price, Maintains Buy Ratin GuruFocus • Feb 21, 2026 Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million The Motley Fool • Jan 31, 2026 Have Amylyx Pharmaceuticals Insiders Been Selling Stock? simplywall.st • Oct 5, 2025
● Gemini Agentic AI Analyst Insight for AMLX
Market Education
View All Articles →
External Research